Zhaoke Ophthalmology (HKG:6622) awarded 8 million share options to 97 grantees on Sept. 5 under its post-IPO share option scheme, a Monday Hong Kong bourse filing said.

Of the total, nearly 6 million options were granted to 90 employees, and nearly 2.1 million options were granted to seven grantees who are either directors and/or the firm's CEO.